
CLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk.
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
#DoctorPodcasts Episode 117:
Breast cancer kills 42,000+ women in the USA annually. Connie Lehman, MD, PhD & Jeff Luber, JD, MBA of CLAIRITY, Inc. have received FDA authorization for the first A.I.-powered mammography tool - CLAIRITY BREAST - that predicts 5-year cancer risk. It will save many lives. For details go to Clairity.com
Watch all 117 DoctorPodcasts || Cykiert Files video podcast interview episodes with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.
#BreastCancerPrediction
#FDAuthorizedAI
#ClairityBreast
#ArtificialIntelligence
#MammographyTool
#CancerRiskPrediction
#WomensHealth
#MedicalInnovation
#HealthcareTechnology
#DoctorPodcasts
#CykiertFiles
#Episode117
#ConnieLehman
#JeffLuber
#CLAIRITYInc
#FiveYearRisk
#EarlyDetection
#PersonalizedMedicine
#AIinHealthcare
#BreastCancerAwareness
#MedicalPodcasts
#HealthcareExperts
#InnovationInMedicine
#TechInHealthcare
#RiskAssessment
#PreventiveHealthcare
#DigitalHealth
#MedicalResearch
#ClinicalOncology
#ASCO2025
#FDAApproval
#HealthTech
#PrecisionMedicine
#CancerPrevention
#MammogramScreening
#AIHealthcareSolutions
#FutureOfMedicine
#HealthInnovation
#MedicalBreakthroughs
#PatientCare
#RobertCykiert
#RobertCykiertMD